日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation

贝拉西普和其他生物制剂在实体器官移植中治疗药物监测的潜力

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.16170
Bergan, Stein; Vethe, Nils Tore
发表日期：2025
文献求助 收藏

Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-Lives

短期停用阿托伐他汀后，低密度脂蛋白胆固醇显著升高，且与代谢物半衰期相关。

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.70082
Pivoriunas, Jonas; Vethe, Nils Tore; Kristiansen, Oscar; Bergan, Stein; Husebye, Einar; Munkhaugen, John; Sverre, Elise
代谢
发表日期：2025
文献求助 收藏

Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study

一项关于家族性高胆固醇血症女性母乳喂养、血脂谱和心血管风险标志物的前瞻性研究：FH-FEMINA 研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-092208
Klevmoen, Marianne; Mulder, Janneke W C M; Bogsrud, Martin P; Retterstøl, Kjetil; Vesterbekkmo, Elisabeth K; Pedersen, Eva K R; Freiberger, Tomas; Vrablik, Michal; Vaclova, Martina; Hovland, Anders; Vethe, Nils Tore; Brekke, Hilde Kristin; Iversen, Per Ole; Veierød, Marit; Roeters van Lennep, Jeanine; Holven, Kirsten B
代谢
发表日期：2025
文献求助 收藏

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone

羟氯喹、卡非佐米和地塞米松联合抑制蛋白酶体和自噬治疗复发/难治性多发性骨髓瘤的I期临床试验

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.1091
Slørdahl, Tobias S; Askeland, Frida Bugge; Hanssen, Margrete Sofie Sætre; Hov, Håkon; Sundt-Hansen, Stine Marie; Lindahl, Sofia; Vethe, Nils Tore; Hjorth-Hansen, Henrik; Fenstad, Mona H; Waage, Anders; Hjertner, Øyvind; Schjesvold, Fredrik; Sundan, Anders
多发性骨髓瘤
Autophagy
自噬
骨髓瘤
发表日期：2025
文献求助 收藏

The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study

阿托伐他汀在肌肉组织和血浆中的代谢物模式与冠心病患者服用他汀类药物后的肌肉副作用相关；一项探索性病例对照研究

期刊:Atherosclerosis Plus
影响因子:2.1
doi:10.1016/j.athplu.2024.01.001
Lauritzen, Trine; Munkhaugen, John; Bergan, Stein; Peersen, Kari; Svarstad, Anja Camilla; Andersen, Anders M; Pahnke, Jens; Husebye, Einar; Vethe, Nils Tore
心血管
冠心病
代谢
发表日期：2024
文献求助 收藏

Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial

阿托伐他汀对伴有自我感知的他汀类药物肌肉副作用的冠心病患者肌肉症状的影响：一项随机、双盲交叉试验

期刊:European Heart Journal-Cardiovascular Pharmacotherapy
影响因子:6.1
doi:10.1093/ehjcvp/pvaa076
Kristiansen, Oscar; Vethe, Nils Tore; Peersen, Kari; Wang Fagerland, Morten; Sverre, Elise; Prunés Jensen, Elena; Lindberg, Morten; Gjertsen, Erik; Gullestad, Lars; Perk, Joep; Dammen, Toril; Bergan, Stein; Husebye, Einar; Otterstad, Jan Erik; Munkhaugen, John
心血管
冠心病
发表日期：2021
文献求助 收藏

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients-A Cross-Validation Study

在儿科患者毛细管体积微量样本中测定他克莫司——一项交叉验证研究

期刊:Therapeutic Drug Monitoring
影响因子:2.4
doi:10.1097/FTD.0000000000000873
Kindem, Ingvild Andrea; Bjerre, Anna; Åsberg, Anders; Midtvedt, Karsten; Bergan, Stein; Vethe, Nils Tore
发表日期：2021
文献求助 收藏

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects

冠心病患者服用他汀类药物后出现肌肉副作用的临床和心理因素

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-021-02422-7
Peersen, Kari; Munkhaugen, John; Sverre, Elise; Kristiansen, Oscar; Fagerland, Morten; Vethe, Nils Tore; Perk, Joep; Husebye, Einar; Dammen, Toril
心血管
冠心病
发表日期：2021
文献求助 收藏

Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells.

比较 mTOR 抑制剂阿奇霉素和雷帕霉素对体外扩增的调节性 T 细胞的影响

期刊:Cell Transplantation
影响因子:3.2
doi:10.1177/0963689719872488
Bergström Marcus, Müller Malin, Karlsson Marie, Scholz Hanne, Vethe Nils Tore, Korsgren Olle
细胞生物学
mTOR
发表日期：2019
文献求助 收藏

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids

与单独使用他克莫司或西罗莫司相比，体外实验表明，二者联合治疗对人胰岛细胞无额外不良反应，但添加糖皮质激素可减轻这些不良反应。

期刊:Journal of Diabetes Research
影响因子:3.4
doi:10.1155/2016/4196460
Kloster-Jensen, Kristine; Sahraoui, Afaf; Vethe, Nils Tore; Korsgren, Olle; Bergan, Stein; Foss, Aksel; Scholz, Hanne
细胞生物学
Human
免疫/内分泌
发表日期：2016
文献求助 收藏